Brand semaglutide
Sold by NovoCare Pharmacy · Oral tablet · every brand semaglutide record
What you actually pay
Per month
$149
| Medication · Cash/self-pay price via NovoCare Pharmacy, by dose | $149 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Cash/self-pay price via NovoCare Pharmacy, by dose “Self-pay pricing varies by dose. Patients pay $149 for each month of 1.5 mg, $199 per month for 4 mg and $299 per month for 9 mg and 25 mg. One month defined as 1 bottle of 30 tablets.” | Per month$149 | Charged today$149 |
We earn nothing from this link. NovoCare Pharmacy has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
Not yet checked: pharmacy, states, prescriber, cancellation, membership and consult fee.
Notes
- 1. September 2, 2026 — This is Novo Nordisk's own manufacturer site (novocare.com), not an independent telehealth provider — 'NovoCare Pharmacy' is Novo Nordisk's own direct-fulfillment pharmacy program for its brand Wegovy, and this page assumes the patient already has a prescription from their own doctor ('take it to your pharmacy with your prescription'); there is no telehealth consult or prescribing service offered on this page, so prescriber is not-found rather than guessed. Three separate published prices exist for the same drug depending on payer: a commercial-insurance copay as low as $25/month (capped at $100/month in savings), a Medicare price of $50/month via the 'Medicare GLP-1 Bridge program,' and self-pay/cash prices through NovoCare Pharmacy that vary by dose and form ($199/mo rising to $349-$399/mo for the injection pen after an introductory period; $149-$299/mo by dose for the tablet). All are recorded as separate entries per the brief's insurance-vs-cash rule. No cancellation/return policy or served-state list appears on this page; full terms are referenced at external domains (WegovyTerms.com, NovoCarePharmacyTerms.com) that were not part of this fetch.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.